Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking

Frontiers in Immunology(2021)10.3389/fimmu.2021.707690Source: DataRank Database

PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 2.47)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Christian Enevold ORCID,Dres Damgaard ORCID,Niels Ødum ORCID,Peter Garred ORCID,Morten Frisch ORCID

Live enrichment

PubMed:34733271 PMC:PMC8558474 OpenAlex:https://openalex.org/W3206954497

Novo Nordisk Fonden

Grant: NNF21OC0066950

NIAMS NIH HHS

Grant: K08 AR065500

Novo Nordisk Fonden

Grant: NNF15OC0018774

LEO Foundation Skin Immunology Research Center

Grant: Skin Inflammation and Cancer

Novo Nordisk Foundation

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5K08AR065500-04

PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid Arthritis

Congressionally Directed Medical Research Programs

Doris Duke Charitable Foundation

Novo Nordisk Fonden

School of Medicine and Public Health, University of Wisconsin-Madison

Danmarks Frie Forskningsfond

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Gigtforeningen

FWCI

2.47

Citation Percentile

0.9%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2021.707690

GOLDhttps://doi.org/10.3389/fimmu.2021.707690

publisherhttps://doi.org/10.3389/fimmu.2021.707690

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.707690/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34733271

Fields of Study

Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchCytokine Signaling Pathways and InteractionsMedicine0301 basic medicine03 medical and health sciences0302 clinical medicineAdultAgedAged, 80 and overAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidDenmarkFemaleGenetic Predisposition to DiseaseHLA-DRB1 ChainsHumansMaleMiddle AgedPolymorphism, Single NucleotideProtein-Arginine Deiminase Type 4Smoking

MeSH Terms

Anti-Citrullinated Protein AntibodiesProtein-Arginine Deiminase Type 4AdultAgedAged, 80 and overArthritis, RheumatoidDenmarkFemaleHumansMaleMiddle AgedSmokingGenetic Predisposition to DiseasePolymorphism, Single NucleotideHLA-DRB1 Chains

Keywords

Rheumatoid arthritisMedicineImmunologyHuman leukocyte antigenAntigenSingle Nucleotide Polymorphism (SNP)Hla-drb1*04Peptidylarginine Deiminase (Pad)Anti-Citrullinated Proteins Antibodies (Acpa)AdultMaleDenmarkPolymorphism, Single NucleotideAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidProtein-Arginine Deiminase Type 4HumansGenetic Predisposition to DiseaseAgedAged, 80 and overSmokingRC581-607Middle AgedFemaleImmunologic diseases. AllergyHLA-DRB1 Chains

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking

FAIR Checklist

Authors (9)

Funding (13 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)